ARA-290
Product Description
ARA-290 — 10 mg
ARA-290, also known as Cibinetide, is an 11-amino-acid synthetic peptide derived from the tissue-protective region of erythropoietin (EPO). It was developed to selectively activate the Innate Repair Receptor (IRR), a signaling pathway involved in cellular protection, inflammatory regulation, tissue repair, and recovery following injury.
Unlike erythropoietin itself, ARA-290 was specifically engineered to retain tissue-protective signaling without stimulating red blood cell production.
ARA-290 has attracted particular research interest for its potential role in peripheral nerve protection and regeneration, small-fiber nerve health, neuropathic signaling, and inflammatory tissue injury.
Human clinical studies involving subjects with small-fiber neuropathy associated with sarcoidosis and type 2 diabetes have investigated ARA-290 for changes in neuropathic symptoms and nerve-fiber structure. Studies have reported improvements in several measures of neuropathic symptoms and evidence consistent with increased corneal small-nerve-fiber density, making ARA-290 an especially interesting compound in regenerative and neurological research.
Product Description
ARA-290 — 10 mg
ARA-290, also known as Cibinetide, is an 11-amino-acid synthetic peptide derived from the tissue-protective region of erythropoietin (EPO). It was developed to selectively activate the Innate Repair Receptor (IRR), a signaling pathway involved in cellular protection, inflammatory regulation, tissue repair, and recovery following injury.
Unlike erythropoietin itself, ARA-290 was specifically engineered to retain tissue-protective signaling without stimulating red blood cell production.
ARA-290 has attracted particular research interest for its potential role in peripheral nerve protection and regeneration, small-fiber nerve health, neuropathic signaling, and inflammatory tissue injury.
Human clinical studies involving subjects with small-fiber neuropathy associated with sarcoidosis and type 2 diabetes have investigated ARA-290 for changes in neuropathic symptoms and nerve-fiber structure. Studies have reported improvements in several measures of neuropathic symptoms and evidence consistent with increased corneal small-nerve-fiber density, making ARA-290 an especially interesting compound in regenerative and neurological research.
Key Benefits & Applications
Peripheral nerve and small-fiber nerve research
Tissue protection and cellular repair signaling
Neuroinflammation and inflammatory regulation
Neuropathic pain pathways
• Nerve-fiber regeneration
• Recovery following cellular or tissue injury
• Innate Repair Receptor (IRR) signaling
Research-Grade Specifications
Product: ARA-290 (Cibinetide)
Form: Lyophilized peptide
Quantity: 10 mg per vial
Research Category: Tissue Repair & Neuroregenerative Research
Testing: Identity, purity, and batch-specific analytical verification
Documentation: Batch-specific Certificate of Analysis (COA)
Handling & Storage
Store lyophilized ARA-290 under refrigerated or frozen conditions according to validated product specifications. Protect from excessive heat, moisture, and direct light.
Following reconstitution, stability depends on the diluent, concentration, sterility, and storage conditions used. Avoid repeated freeze-thaw cycles.
Batch Verification
Verify This Batch
Scan the QR code or use the batch number below to view the Certificate of Analysis and testing documentation.
99.92
Scan to verify
Tap QR on mobile to open verification
